About Aceto
Data last updated:
Aceto is a company based in New York (United States) founded in 1947. Aceto has completed 8 acquisitions, including A&C, A&C Bio Buffer and Biotron Laboratories. Aceto offers products and services including Analytical Services, GMP Contract Manufacturing, and R&D Services. Aceto operates in a competitive market with competitors including Almac Group, Asymchem, Seqens, Aurobindo Pharma and Aptuit, among others.
- Headquarter New York, United States
- Stage Public
- SectorsHealthcare
- PhoneLocked
- WebsiteLocked
- SocialLocked
- Legal Name Aceto Pharma (India) Private Limited
- Date of Incorporation 29 Jan, 2007
- Jurisdiction Sanand, Gujarat, India
- Annual Revenue$42.29 M (USD)19.24as on Mar 31, 2023
- Net Profit$8.14 M (USD)107.06as on Mar 31, 2023
- EBITDA$11.08 M (USD)90.59as on Mar 31, 2023
- Latest Funding Round$144 M (USD), Post-IPO
Nov 11, 2015
- InvestorsNot available
- Employee CountNot available
- Investments & AcquisitionsA&C
& 7 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Aceto
Aceto is a publicly listed company on the NASDAQ with ticker symbol ACET in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Aceto
Aceto offers a comprehensive portfolio of products and services, including Analytical Services, GMP Contract Manufacturing, and R&D Services.
Offers testing for raw materials in multiple industries
Provides contract production of APIs and intermediates
Delivers custom research and scale-up for ingredient solutions
People of Aceto
Unlock access to complete
Unlock access to complete
Funding Insights of Aceto
Investments & Acquisitions by Aceto
Aceto has strategically engaged in corporate development activities, having acquired 8 companies. Notable acquisitions include A&C, A&C Bio Buffer and Biotron Laboratories.
Investment portfolio details for Aceto
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
GMP biological buffers, cleaning solutions, and related products are manufactured. | Locked | Locked | 2018 | Locked | |
Mineral ingredient consulting services are provided to industry clients. | Locked | Locked | 2014 | Locked | |
Pharmaceutical, agrochemical, aroma, and polymer chemicals are manufactured and supplied. | Locked | Locked | 2004 | Locked |
Complete acquisition details for Aceto
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Aceto
Detailed financials for Aceto
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aceto Comparisons
Peer comparison for Aceto
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aceto
Aceto operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Asymchem, Seqens, Aurobindo Pharma and Aptuit, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked | Integrated CDMO services for biopharma R&D and manufacturing are offered. | |
| Locked | Locked | Locked | APIs and peptides are developed and manufactured by Asymchem. | |
| Locked | Locked | Locked | Contract manufacturing services for small molecules and peptides are provided. | |
| Locked | Locked | Locked | Generic biocatalytic solutions are provided for pharmaceutical applications. | |
| Locked | Locked | Locked | Contract research and development services for small molecules are offered. | |
| Locked | Locked | Locked | APIs manufacturing and formulation services are provided in therapeutic segments. |
Detailed competitors of Aceto
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aceto
Complete news archive for Aceto
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aceto
Aceto was founded in 1947 and raised its 1st funding round 68 years after it was founded.
Aceto is headquartered in New York, United States. It is registered at New York, New York, United States.
Annual revenue of Aceto is $42.29M as on Mar 31, 2023.
Aceto was founded in 1947 in New York, United States, within the chemicals and pharmaceuticals sector. Marketing, sale, and distribution of human health products, pharmaceutical ingredients, and performance chemicals are handled by the company. Finished dosage form generics and nutritionals form part of human health offerings. APIs and pharmaceutical intermediates constitute the pharmaceutical ingredients. Specialty chemicals and agricultural protection products are included in performance chemicals.
Aceto's top competitors include Concord Biotech, Almac Group and Indoco Remedies.
Aceto offers Analytical Services, GMP Contract Manufacturing, and R&D Services.
Yes, Aceto is publicly traded on NASDAQ under the ticker symbol ACET.
Aceto has made 8 acquisitions, including A&C, A&C Bio Buffer, and Biotron Laboratories.
The ticker symbol of Aceto is ACET on NASDAQ.